Skip to content

A clinical trial to study the effect of Hinguvachadi vati orally in comparison with Kanchanara guggulu orally in the management of Hypothyroidism in adults of age group 18-60 years for a period of 45 days

To study the efficacy of Hinguvachadi vati in comparison with Kanchanara guggulu in Hypothyroidism: A controlled randomized clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080896
Enrollment
30
Registered
2025-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Dr Ananya D R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the diagnostic criteria between the age of 18 years to 60 years with irrespective sex, caste and religion. 2. Thyroid stimulating hormone (TSH) level more than 4.25mIL/ml (preferably upto 60mIU/ml) 3. Fresh cases and patients on medication of hypothyroidism maintaining the manufacturer and batch compulsorily with persisting signs and symptoms and altered quality of life.

Exclusion criteria

Exclusion criteria: 1. Patients with age below 18years and above 60 years. 2. If serum TSH level more than 60uIL/ml. 3. Patients who have under gone any type of thyroid surgery. 4. Patients with congenital and secondary hypothyroidism. 5. Patients suffering from systemic diseases like Cardiac disorders, uncontrolled Diabetes, uncontrolled Hypertension, Carcinoma and Sepsis. 6. Drug induced hypothyroidism, Myxedema coma, neoplasia and toxic goiter. 7. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Improvements noticed in reduction of signs and symptoms in patients diagnosed with Hypothyroidism with Zulewski s scale.Timepoint: 0th day (baseline), 45th day, 60th day and 75th day

Secondary

MeasureTime frame
Improvements noticed in the thyroid profile levels along with Quality of life.Timepoint: 0th day (baseline), 45th day, 60th day and 75th day

Countries

India

Contacts

Public ContactDr Ananya D R

Shri Dharmasthala Manjunatheswara Institute of Ayurveda and Hospital

ssomayaji78@gmail.com09448211053

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026